Newsbenzinga
Pfizer Prepares Global Regulatory Litfulo Filings Following Skin Pigment Improvements In Late-Stage Trials
· Published
Article summary
Pfizer reports Phase 3 data for LITFULO in treating nonsegmental vitiligo and plans to submit global regulatory filings.
An excerpt from the original article.
Comments —
Loading comments…